CASOKEFAMIDE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C33H40N6O7
Molecular Weight	632.7067
Optical Activity	UNSPECIFIED
Defined Stereocenters	5 / 5
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H](C)C(=O)N[C@@H](CC3=CC=C(O)C=C3)C(N)=O

InChI

InChIKey=XDRHVZLDLNGKLM-FLVVDCEDSA-N

InChI=1S/C33H40N6O7/c1-19(36-32(45)26(34)16-22-8-12-24(40)13-9-22)31(44)39-28(18-21-6-4-3-5-7-21)33(46)37-20(2)30(43)38-27(29(35)42)17-23-10-14-25(41)15-11-23/h3-15,19-20,26-28,40-41H,16-18,34H2,1-2H3,(H2,35,42)(H,36,45)(H,37,46)(H,38,43)(H,39,44)/t19-,20-,26+,27+,28+/m1/s1

HIDE SMILES / InChI

Molecular Formula	C33H40N6O7
Molecular Weight	632.7067
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	5 / 5
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11021978 | https://www.ncbi.nlm.nih.gov/pubmed/10793229 | https://www.ncbi.nlm.nih.gov/pubmed/8466524

Casokefamide is a synthetic peptide derived from the beta-casomorphin sequence, designed to increase the resistance to gastric proteases. . Casokefamide binds to both mu and delta-opioid receptors, while beta-casomorphins and its fragments are typical mu-opioid receptor agonists. Furthermore, casokefamide can affect gastric acid and pancreatic exocrine secretions and also gastrointestinal motility.

Originator

Approval Year

PubMed

Title	Date	PubMed

Patents

Sample Use Guides

In Vivo Use Guide

16.0 mg/day

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:28:55 GMT 2023` Edited by `admin` on `Fri Dec 15 16:28:55 GMT 2023`
Record UNII	B453T1E8MP
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CASOKEFAMIDE

Official Name

English

casokefamide [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C67413